Dieter Schollaert

Androgens have antiresorptive effects on trabecular disuse osteopenia independent from muscle atrophy.

F. Claessens, D. Vanderschueren, G. Carmeliet, 2016, Bone.

A shortened tamoxifen induction scheme to induce CreER recombinase without side effects on the male mouse skeleton

F. Claessens, D. Vanderschueren, B. Decallonne, 2017, Molecular and Cellular Endocrinology.

Androgen Receptor in Neurons Slows Age‐Related Cortical Thinning in Male Mice

F. Claessens, D. Vanderschueren, B. Decallonne, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Estrogen receptor alpha signaling in extrahypothalamic neurons during late puberty decreases bone size and strength in female but not in male mice

Na Ri Kim, J. Gustafsson, M. Lagerquist, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Androgen action on renal calcium and phosphate handling: Effects of bisphosphonate treatment and low calcium diet

Na Ri Kim, F. Claessens, D. Vanderschueren, 2020, Molecular and Cellular Endocrinology.

Testosterone boosts physical activity in male mice via dopaminergic pathways

R. D'Hooge, F. Claessens, D. Vanderschueren, 2018, Scientific Reports.

Testosterone Reduces Body Fat in Male Mice by Stimulation of Physical Activity Via Extrahypothalamic ERα Signaling

J. Gustafsson, C. Ohlsson, F. Claessens, 2021, Endocrinology.

Effects of sex hormone-binding globulin (SHBG) on androgen bioactivity in vitro

F. Claessens, D. Vanderschueren, B. Decallonne, 2016, Molecular and Cellular Endocrinology.

Testosterone boosts physical activity in male mice via dopaminergic pathways

R. D'Hooge, F. Claessens, D. Vanderschueren, 2018, Scientific Reports.

Androgens have antiresorptive effects on trabecular disuse osteopenia independent from muscle atrophy.

F. Claessens, D. Vanderschueren, G. Carmeliet, 2016, Bone.

Changes in bone and mineral homeostasis after short-term androgen deprivation therapy with or without androgen receptor signalling inhibitor – substudy of a single-centre, double blind, randomised, placebo-controlled phase 2 trial

L. Antonio, G. Devos, Dieter Schollaert, 2023, EBioMedicine.